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a  b  s  t  r  a  c  t
The  release  of extracellular  vesicles  (EV)  by the syncytiotrophoblast  (STB)  may  be an  important  mecha-
nism by which  the  placenta  signals  to  the  mother.  STB  derived  EV  (STBEV)  are  comprised  predominantly
of  exosomes  (50–150  nm)  and microvesicles  (100–1000  nm)  that  contain  bioactive  mediators  such  as
proteins,  nucleic  acids  and  lipids.  They,  along  with  larger  syncytial  nuclear  aggregates  are  released  by
the  STB  into  the  maternal  circulation  throughout  gestation  in  normal  pregnancy  where  they  appear  to
have  an  immunoregulatory  role, inhibiting  T cell  and  NK cell  responses.  In  pre-eclampsia  (PE)  STBEV
are  released  in signiﬁcantly  increased  numbers  and  have  pro-inﬂammatory,  anti-angiogenic  and  proco-
agulant  activity,  implicating  them  in  the  maternal  systemic  inﬂammation,  endothelial  dysfunction  and
activation  of  the  clotting  system  which  typiﬁes  the disorder.  Research  has focused  on  understanding  thexosomes biological  signiﬁcance  of  STBEV  by  measuring  their  size  and  repertoire  of  molecules  carried  and  how
they  differ  in normal  pregnancy  and PE,  using  techniques  such  as  Nanoparticle  Tracking  Analysis,  ﬂow
cytometry  and  mass  spectrometry.  We  have  also  found  alterations  in  STBEV  surface  glycans  associated
with PE.  The  goal  is to better  understand  the  role  STBEV  play in  normal  pregnancy  and  PE and  whether
they  are  potential  biomarkers  of  placental  pathology  and  therapeutic  targets  in  PE.
©  2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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. Introduction
The syncytiotrophoblast (STB); a multinucleated, terminally dif-
erentiated, polarised epithelium that covers the entire surface of
uman placental villi, is one of the largest cell types in human biol-
gy (Burton and Fowden, 2015). It forms during the early stages of
mbryo development by the initial fusion of mononuclear cytotro-
hoblasts and then is maintained throughout gestation by a process
f turnover, with spent material shed from the apical surface being
eplenished by incorporation of underlying cytotrophoblast cells
Huppertz et al., 2006). It is the largest and most critical fetal-
aternal interface, responsible for nutrient uptake, gas exchange,
aste removal, protein and steroid hormone production and mod-
lation of maternal physiology. The STB is also specially adapted
o shield the fetus from the maternal immune system. The semi-
llogeneic STB is unique in being human leukocyte antigen (HLA)
ull and therefore immunologically inert to prevent allorecogni-
ion and rejection by maternal T cells (Nancy and Erlebacher, 2014).
hile this lack of HLA expression might be expected to render the
TB open to attack by maternal natural killer cells (NK cells; which
re programmed to destroy HLA negative tumour cells), there is
o evidence that this occurs. This may  be due to the presence of
 glycocalyx on the STB membrane which could prevent interac-
ions with NK cells (Arkwright et al., 1994). The STB communicates
ith the maternal immune system using both soluble factors, such
s chemokines, cytokines and steroid and protein hormones, and
actors carried by extracellular vesicles (EV).
EV are cell-derived membranous vesicles and potent media-
ors of both physiological and pathological processes (Colombo
t al., 2014). The term EV encompasses three main vesicle types:
xosomes, microvesicles (also known as ectosomes and micropar-
icles) and apoptotic bodies. EV biology has been extensively
eviewed for comprehensive reviews see (Colombo et al., 2014;
alra et al., 2016), so brieﬂy, exosomes are the smallest vesicle type
∼50–150 nm)  and are produced in a constitutive manner, using
achinery of the endocytic pathway, in structures called multi-
esicular bodies (MVB), which enable loading with a targeted cargo
ollowed by release of exosomes into the extracellular environment
y fusion with the plasma membrane and exocytosis. Microvesicles
∼100 nm–1 m)  are released directly from the plasma membrane
n response to stimuli that cause a rise in intracellular calcium
evels and cytoskeletal remodeling such as cellular activation or
tress. Also included under the umbrella of EV are apoptotic bodies
hich overlap in size with microvesicles (∼200 nm–5 m)  and are
eleased from apoptosing cells, but only once in the life of a cell as
t is a terminal event in the apoptotic pathway. As such, research
nto the role of EV in cell–cell communication has tended to focus
n microvesicles and exosomes. EV carry proteins, lipids and RNAs
such as mRNA, miRNA, vaultRNA and tRNAs) and are thought to
ignal to their target cells via surface interactions including protein
r lipid ligand-receptor binding, by fusing and releasing their con-
ents into the cytosol of the target cell and ﬁnally via endocytosis
nd subsequent fusion with endosomes (Raposo and Stoorvogel,
013).
EV release appears to be evolutionarily conserved, involving
he coordinated activity of numerous proteins (comprehensively
eviewed by (Colombo et al., 2014)). The transmembrane proteins
etraspanins, including CD9, CD81, CD82 and CD63, clustered in
etraspanin enriched domains (TEMs) in the plasma membrane
nd the endosomal sorting complex required for transport (ESCRT)
omplex, made up of around 30 different proteins including ALIX,
SG101, syntenin and multiple RAB proteins, are major compo-Please cite this article in press as: Tannetta, D., et al., Update of syncyt
and preeclampsia. J. Reprod. Immunol. (2016), http://dx.doi.org/10.10
ents of EV biogenesis, involved at multiple stages in a cell speciﬁc
anner (Henne et al., 2011; Friand et al., 2015; Stuffers et al., 2009).
EMs act as specialized scaffolds, enabling the compartmental-
zation of proteins from the plasma membrane into EVs and the PRESS
e Immunology xxx (2016) xxx–xxx
downstream sorting of proteins and possibly RNA and lipids into
EV cargo (Villarroya-Beltri et al., 2014; Mazurov et al., 2013). Com-
ponents of the ESCRT complex are required for endocytosis of the
endosomal membrane wall to form exosomes, targeting of MVB  for
fusion with the plasma membrane for exosome exocytosis and EV
release (Hanson and Cashikar, 2012). The selective recruitment of
proteins, such as adhesion molecules, glycoproteins and external-
ization of phosphatidylserine (PS) also enables the targeting of EV
to particular recipient cells following their release, while patholog-
ical cellular changes lead to characteristic alterations in EV cargo
(Colombo et al., 2014; Andreu and Yanez-Mo, 2014).
The STB is the primary source of placenta derived EV, that may
constitute a major signaling mechanism between fetus and mother,
augmenting maternal physiology to allow the presence and meet
the demands of the developing fetus. Pregnancy is an ideal sys-
tem to study EV as the entire process has a deﬁnite start and
end point, with speciﬁc STB markers, principally placental alkaline
phosphatase (PLAP), distinguishing STB derived EV (STBEV) from
those produced by other cell types, and availability at the end of
pregnancy of the STBEV source, the placenta. This is particularly
relevant to the investigation of pregnancy disorders driven by pla-
cental dysfunction, such as preeclampsia (PE); a problem of human
pregnancy and leading cause of maternal mortality (Tannetta and
Sargent, 2013; Redman et al., 2012). PE affects 2–5% of women
worldwide and carries a substantial risk of long-term cardiovascu-
lar health for both the mother and baby. It is characterized by the
maternal signs of hypertension, proteinuria and hypercoagulation,
triggered by the release of placental proinﬂammatory, antiangio-
genic and procoagulant factors in response to ischemia reperfusion
and downstream inﬂammatory and endoplasmic reticulum (ER)
stresses (Redman and Sargent, 2005; Burton and Yung, 2011).
This review will outline our current understanding of STBEV
subtypes, interactions of STBEV with maternal cells, potential novel
mediators of these interactions including altered STBEV surface
glycan groups and their possible role in pregnancy and PE.
2. STBEV release and composition in normal pregnancy and
PE
It has been known for many years that release of membranous
material into the maternal circulation by the STB is a feature of
normal pregnancy (Burton and Jones, 2009). This material, rang-
ing from multinucleated syncytial sprouts and knots (known as
syncytial nuclear aggregates (SNA)) and viable trophoblast cells
to STBEV has, until relatively recently, been regarded as inert STB
debris of little consequence. However, the demonstration of their
immunomodulatory activities has increased interest in their role in
both normal and pathological pregnancies, particularly PE.
Given their size, SNA can easily be isolated using low speed
centrifugation (Abumaree et al., 2006b). However, the subcellu-
lar nature of STBEV means that specialised isolation protocols are
required. There is no consensus in the ﬁeld of EV research on proto-
cols for the isolation of speciﬁc EV subtypes. Efforts to standardise
isolation procedures may  also not be practical given the range of
biological ﬂuids that contain EV (e.g. plasma, urine, saliva, cere-
brospinal ﬂuid, breast milk) and in vitro culture systems used in EV
research (Witwer et al., 2013). Methods routinely used to isolate
EV include precipitation, differential centrifugation, density gradi-
ent ultracentrifugation, ﬁltration, size exclusion chromatography
and immunocapture on beads or chips. Sample type (ranging from
complex biological ﬂuids such as plasma to in vitro derived samplesiotrophoblast derived extracellular vesicles in normal pregnancy
16/j.jri.2016.08.008
such as conditioned media) and downstream analyses (e.g. cargo
determination using transcriptomic and proteomic approaches
or EV characterization techniques such as electron microscopy,
ﬂow cytometry and nanoparticle tracking analysis (NTA)) will
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etermine the choice of isolation technique due to effects of sample
omplexity, sample volume, EV yield, enrichment of certain EV sub-
ypes and purity of the resultant preparation (Xu et al., 2016). Each
solation method has its advantages and disadvantages that have
een comprehensively discussed in recent reviews (Momen-Heravi
t al., 2013; Xu et al., 2016; Gudbergsson et al., 2016; Van Deun et al.,
014). Brieﬂy, centrifugation techniques are most commonly used
o isolate EV and have proved useful to fractionate large and small
TBEV from placental perfusate (Dragovic et al., 2015). However, as
ith precipitation techniques, ultracentrifugation can lead to con-
amination of pelleted EV with protein aggregates and, in the case
f blood derived samples such as plasma, also high density lipopro-
eins, that can interfere in downstream analyses (Yuana et al., 2014;
omen-Heravi et al., 2013). Size exclusion chromatography (SEC) is
uick and gives high EV yields with minimal contaminating soluble
nd aggregated proteins (Boing et al., 2014). For even greater purity
nd enrichment of particular EV phenotypes, immunocapture using
ntibodies to speciﬁc surface antigens has proved effective in the
eld of cancer biomarker research (An et al., 2015). Similar strate-
ies may  enable the routine isolation of STBEV from plasma and use
s circulating biomarkers of placental status.
Efforts to characterize EV are also hampered by the lack of spe-
iﬁc features unique to each EV subtype, therefore measurement
f multiple parameters is required to allow a general assessment
f EV cellular and subcellular origin. EV size can be measured rou-
inely using NTA, to determine whether EV are in the expected size
ange of exosomes (∼100 nm)  or microvesicles (∼100 nm–1 m)
Dragovic et al., 2011). Given their role in exosome biogene-
is, tetraspanins, particularly CD63 and ESCRT components such
s ALIX and TSG101 are routinely employed as exosome mark-
rs, in techniques such as Western blotting and immunocapture
ssays. However, doubts have been raised regarding CD63 exo-
ome speciﬁcity, which is not unexpected as tetraspanin enriched
icrodomains and all EV both originate from the plasma membrane
Colombo et al., 2014). A buoyant density of 1.13–1.19 g/mL is also
eported to be indicative of exosomes, but again this is not deﬁnitive
Colombo et al., 2014). Much of the characterization of EV has been
arried out on EV prepared from cancer derived cell lines and the
eneral ﬁndings applied to STBEV. No in-depth studies of expres-
ion of the known TEMs and ESCRT complex components by STB
ave been reported. This is critical considering the unique nature
f STB biology and the heterogeneity already reported amongst
ifferent cell types.
Given the caveats outlined above, the general consensus is that
TB release the full range of EV; exosomes, microvesicles and
poptotic bodies (Dragovic et al., 2015) (Fig. 1). Unique to STB, mult-
nucleated material, in the form of SNA, are also released (Fig. 1).
he biological signiﬁcance of each remains to be determined. Exam-
nation of in vitro placenta explant culture supernatant, ex vivo
lacental lobe maternal side perfusate and uterine vein plasma
ives an insight into the full repertoire of EV and SNA released by
he STB (Chamley et al., 2011; Dragovic et al., 2015; Johansen et al.,
999). Larger STB material, such as SNA can easily be isolated from
lacenta explant culture supernatants and maternal side placenta
erfusates by low speed centrifugation (∼400×g) (Fig. 1). Mean-
hile, differential centrifugation has predominantly been used to
solate both total STBEV preparations and fractions enriched in
icrovesicles or nanovesicles (Dragovic et al., 2015) (Fig. 1). Larger
TB derived vesicles and fragments have been found in uterine
ein blood but not in peripheral blood, reﬂecting their seques-
ration in the pulmonary capillary bed (Johansen et al., 1999).
owever, smaller STBEV pass unimpeded into the peripheral circu-Please cite this article in press as: Tannetta, D., et al., Update of syncyt
and preeclampsia. J. Reprod. Immunol. (2016), http://dx.doi.org/10.10
ation (Knight et al., 1998). Using a PLAP based ELISA to distinguish
TBEV from other EV in the circulation, STBEV have been found cir-
ulating at progressively higher levels with advancing pregnancy
Germain et al., 2007) and labour (Reddy et al., 2008), returning PRESS
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to non-pregnant levels around 48 h post-delivery. PLAP and CD63
double positive EV were detected from as early as 6 weeks gestation
and as with total PLAP positive EV, levels increased over the course
of pregnancy (Salomon et al., 2014). Flow cytometry, using STB spe-
ciﬁc monoclonal antibodies NDOG2 (recognizes PLAP) and ED822
(antigen unknown), has also been used to analyse STBEV pelleted
from maternal plasma but, with a detection threshold of ∼300 nm,
discriminates in favour of EV in the size range of large MV and apop-
totic bodies, unlike immunoassay based methods that measure all
STB marker positive EV irrespective of size (Dragovic et al., 2013).
Maternal plasma STBEV, measured by ELISA, are increased in
PE. Increased levels tend to reﬂect disease severity. Increased lev-
els were not detected in normotensive fetal growth restriction,
another pregnancy complication commonly associated with pla-
cental dysfunction (Knight et al., 1998; Goswami et al., 2006; Chen
et al., 2012a,b). A signiﬁcant increase in circulating STBEV in PE
women during labour, may  also play a part in worsening maternal
symptoms in the postpartum period (Reddy et al., 2008). Results
of ﬂow cytometry studies have been less consistent with both
increased plasma levels of STBEV in PE and no difference between
PE and normal pregnancy being found, perhaps reﬂecting the need
to differentiate severe from mild forms of the disease (Lok et al.,
2008; Orozco et al., 2009; Marques et al., 2012; Dragovic et al.,
2013; Germain et al., 2007). Given the bias of ﬂow cytometric anal-
ysis towards larger EV, poor consistency also suggests increases
found with immunoassay based measurements are due to changes
in STBEV subtypes below the detection threshold of ﬂow cytome-
try. Indeed, NTA analysis showed a signiﬁcant increase in placental
perfusate derived total STBEV median size in PE, compared to nor-
mal  pregnancy (201 nm vs 166 nm respectively) suggesting a shift
towards release of more microvesicles and a potential impact on
overall functional effects (Tannetta et al., 2013).
3. Cellular interactions of STBEV in normal and PE
pregnancies
Adaptation of maternal immune responses to accommodate and
support the development of the semiallogeneic fetus are critical
for a successful pregnancy. Failure of the maternal immune system
to respond appropriately to pregnancy may  contribute to serious
obstetric complications such as miscarriage, preterm labour and
PE. Evidence supporting a role for STB derived EV and larger mate-
rial in the complex modulation of maternal immune cell function
continues to grow. Results derived from in vitro studies suggest a
tolerising effect of STB derived exosomes and SNA on the maternal
adaptive immune response from the ﬁrst trimester onwards. Pub-
lished data also support a role for STBEV in activation of maternal
innate immunity seen during normal pregnancy and the exagger-
ated systemic inﬂammatory response, vascular dysfunction and
hypercoagulation associated with PE. However, conﬁrmation using
in vivo models have not been performed. Results of published stud-
ies investigating the biological effects of STBEV on maternal cells in
normal pregnancy and PE are summarized below.
3.1. Neutrophils
Neutrophilia is one of the ﬁrst clinical changes of early preg-
nancy. In the second trimester it is associated with inﬁltration of
the decidua by a unique subset of neutrophils (N2) that endow
immunosuppressive and angiogenic functions (Amsalem et al.,
2014). Their importance is underlined by pregnancy pathology, iniotrophoblast derived extracellular vesicles in normal pregnancy
16/j.jri.2016.08.008
mildly hypertensive BPH/5 mice, which have maternal decidual
arteriopathy, abnormal placentation and fetal growth restric-
tion. These problems are mediated by classical neutrophils (N1)
which are recruited by complement activation to areas of aberrant
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Fig. 1. Syncytial nuclear aggregates (SNA) and syncytiotrophoblast (STB) derived extracellular vesicles (STBEV) isolated by ex vivo placental perfusion method. A) SNA
(20–500  m)  are released from the STB on the placental surface. Here SNA have been ﬂuorescently labelled for STB marker placental alkaline phosphatase (PLAP; green),
anti-inﬂammatory molecule CD200 (red) and nuclei (blue). B) Microvesicles (100 nm–1 m)  are produced by direct budding of the plasma membrane in response to stimuli
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ecidual inﬂammation (Gelber et al., 2015). In the third trimester of
ormal human pregnancy circulating neutrophils are activated but
ore so in pre-eclampsia (Sacks et al., 1998). STBEV prepared from
re-eclampsia placentas induce increased superoxide production
y neutrophils (Aly et al., 2004) and may  contribute to the increased
ETs in the intervillous space of PE placentae (Gupta et al., 2005a).
hese studies, implicate STBEV activated neutrophils in the etiology
f placental pathology and the exaggerated systemic inﬂammation
f PE. Interactions of STBEV with other granulocytes have not been
nvestigated.
.2. Monocytes and macrophages
There is strong evidence of interactions between STBEV and
NA and monocytes/macrophages in normal pregnancy and PE.
rimary monocytes rapidly bind and internalise STBEV both in
itro and in vivo (Germain et al., 2007; Southcombe et al., 2011).
hen monocytic U937 cells or primary macrophages are incu-
ated with SNA anti-inﬂammatory changes are induced. ThesePlease cite this article in press as: Tannetta, D., et al., Update of syncyt
and preeclampsia. J. Reprod. Immunol. (2016), http://dx.doi.org/10.10
nclude increased anti-inﬂammatory cytokine release such as IL-10
nd indoleamine 2,3-dioxygenase (IDO) expression and decreased
ro-inﬂammatory cytokine secretion and MHC  class II molecule
urface expression (Abumaree et al., 2006a; Abumaree et al.,sed from cells undergoing apoptosis. C) Exosomes (50–150 nm)  are generated from
uses with the plasma membrane of the cell and releases exosomes by exocytosis.
2012), ascribed to the apoptotic nature of the SNA. The authors
suggest that the capture and clearance of larger apoptotic STB
debris by alveolar macrophages and circulating monocytes may
tolerise maternal immune cells to fetal alloantigens (Chamley et al.,
2011). Down regulation of innate immune response may  also occur
through the actions of STBEV and syncytial nuclear aggregate asso-
ciated CD200, an anti-inﬂammatory molecule. We  have found
high expression of CD200 associated with SNA and STBEV (Fig. 1)
(Sargent, 2013).
Suppression of maternal adaptive immune cell activity might
contribute to a mechanism by which the placenta avoids
immune rejection. However, a systemic inﬂammatory state due
to controlled activation of maternal innate immune responses
is characteristic of normal pregnancy, perhaps a physiological
compensation for suppressed T and NK cell mediated immune
responses (Sacks et al., 1998). That STBEV could stimulate this
maternal systemic inﬂammatory response is suggested by studies
showing that ex vivo preparations of STBEV stimulate peripheral
blood mononuclear cells (PBMCs) and monocytes to release proin-iotrophoblast derived extracellular vesicles in normal pregnancy
16/j.jri.2016.08.008
ﬂammatory cytokines (Messerli et al., 2010; Southcombe et al.,
2011; Atay et al., 2011; Germain et al., 2007). Moreover, treat-
ment of PBMC with STBEV from PE placenta explants stimulate
signiﬁcantly increased release of pro-inﬂammatory cytokines and
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Fig. 2. Internalisation of syncytiotrophoblast extracellular vesicles (STBEV) over time by human umbilical vein endothelial cells (HUVEC). Flow cytometric and immunoﬂu-
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Srescence confocal microscopy assessment of STBEV internalisation over time, us
hosphatase and an appropriate IgG negative control. For immunoﬂuorescence mic
green)  and nuclei with DRAQ-5 (blue).
hemokines, including IL-1, when compared to normal placenta
TBEV (Holder et al., 2012). This suggests qualitative as well as
uantitative differences in STBEV shed in PE.
.3. Dendritic cells
Although dendritic cells (DC) are major phagocytosing and
ntigen presenting cells, no studies have been published to date
nvestigating interactions of DC with STBEV or SNA. When under-
aking these types of studies, maturation of DC due to placenta
erived soluble cytokines should be avoided by careful isolation
nd washing of STBEV.
.4. B cells
Largely ignored in reproductive immunology, B cells are capa-
le of more than just mediating humoral immunity through the
roduction of antibodies (Arck et al., 2015). Although vital for pas-
ive immunization of the neonate for early life protection against
athogens, recent work has also identiﬁed antibody independent
ffects mediated by B cell subsets that secrete distinct cytokine pro-
les and modulate DC, natural killer cell (NK) and T cell immune
esponses (Bao and Cao, 2014; Moulin et al., 2000). B cells rapidly
ind and internalise STBEV, suggesting possible in vivo interactions,
lthough the functional consequences of such interactions are not
nown (Southcombe et al., 2011).
.5. NK cells and T cells
STBEV have broad down-regulatory effects on T cell responses
uch as inhibition of proliferation induced by PHA, the mixed lym-
hocyte response (Gupta et al., 2005b; Thibault et al., 1991) or by
D3-zeta loss (Sabapatha et al., 2006; Taylor et al., 2006) although
he effect depends on how the STBEV are prepared (Gupta et al.,
005b). STBEV express MHC  class I chain-related (MIC A/B) andPlease cite this article in press as: Tannetta, D., et al., Update of syncyt
and preeclampsia. J. Reprod. Immunol. (2016), http://dx.doi.org/10.10
L-16 binding proteins (ULBPs) that are ligands and inhibitors
f the NKG2D receptor of NK cells, cytotoxic T lymphocytes and
d T cells (Hedlund et al., 2009; Mincheva-Nilsson et al., 2006).
TBEV associated Fas ligand and TRAIL also promote lymphocytee monoclonal antibody NDOG2 which binds to the STB marker placental alkaline
py PLAP was labelled with NDOG2-phycoerythrin (red), actin with phalloidin-FITC
and PBMC apoptosis (Stenqvist et al., 2013), and allogeneic reac-
tivity is suppressed by N-linked oligosaccharides of STB membrane
glycoproteins (Arkwright et al., 1994).
As well as general inhibition of T and NK cell cytotoxicity,
factors expressed by STBEV may  also tolerise maternal adaptive
immune responses. Although HLA null, the STB does express pater-
nal derived minor histocompatibility antigens (mHAgs), to which
reactive maternal T-cells can be produced and whose numbers
expand over the course of normal pregnancy, to persist for many
years afterwards. The mHAgs DDX3Y and HA-1 are released by pla-
cental explants bound to SNA and may  constitute a mechanism by
which the maternal immune system is exposed to fetal alloanti-
gens and induces antigen speciﬁc regulatory cytotoxic T cells,
conferring maternal immunological tolerance (Holland et al., 2012;
Linscheid et al., 2015). Interestingly, in a transgenic mouse model
expressing ovalbumin as a surrogate fetal alloantigen, although
pregnancy alone suppressed the induction of ovalbumin reactive
CD8+ T cells when primed with soluble ovalbumin, presentation of
ovalbumin incorporated into shed placental membranous material
blocked its immunogenicity completely (Tay et al., 2013). There-
fore, alloantigen association with STB derived membrane may  also
block immunogenicity in contrast to the effects of the soluble anti-
gens.
These studies suggest involvement of STBEV in the mecha-
nisms that regulate maternal cell mediated immunity in normal
pregnancy. The possible involvement of these STBEV driven mech-
anisms in the pathophysiology of PE has not been investigated.
3.6. Platelets
Excessive activation of the coagulation system and increased
platelet activation are features of PE (Macey et al., 2010). PE pla-
cental perfusion derived STBEV have higher tissue factor activity
and stimulate higher levels of platelet activation than those iso-iotrophoblast derived extracellular vesicles in normal pregnancy
16/j.jri.2016.08.008
lated from normal placentas, (Gardiner et al., 2011; Reverdiau et al.,
1995; Tannetta et al., 2015). Furthermore, aspirin treatment, which
is recommended for women at high risk of developing PE to prevent
platelet aggregation, blocked PE derived STBEV induced platelet
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Fig. 3. Analysis of syncytiotrophoblast extracellular vesicle (STBEV) and placental section glycans. A) Flow cytometric analysis of STBEV glycan expression using plant lectin
binding.  STBEV preparations from normal (n = 10) and preeclampsia derived placentas (PE; n = 10) were labelled with FITC conjugated Sambucus nigra (SN; binds sialic acid)
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ggregation, providing a potential explanation for the beneﬁcial
linical effect of aspirin (Tannetta et al., 2015).
.7. Endothelial cells
Given the endothelial dysfunction that is a central feature of
E, several studies have investigated the effects of SNA and STBEV
n endothelial cells. In normal pregnancy, trophoblastic mate-
ial, such as SNA, released by apoptotic like processes during
he normal turnover of the STB, may  have a suppressive effect
n endothelial immune responses. Phagocytosis of apoptotic tro-
hoblast debris by microvascular and pulmonary artery derived
ndothelial cells in vitro reduced their subsequent response to
ro-inﬂammatory stimuli, such as necrotic trophoblast debris, pre-
iously shown to induce endothelial cell activation (Chen et al.,
006, 2010, 2012a). This may  be important in regulating maternal
ndothelial responses to low levels of STB derived necrotic mate-
ial released during normal pregnancy, especially in the pulmonary
apillary bed which traps a signiﬁcant amount of the large STB
erived material. Furthermore, the transcriptome and proteome of
ndothelial cells exposed to normal placentae derived SNA showed
hanges that may  also contribute to maternal cardiovascular adap-Please cite this article in press as: Tannetta, D., et al., Update of syncyt
and preeclampsia. J. Reprod. Immunol. (2016), http://dx.doi.org/10.10
ations to pregnancy (Wei  et al., 2016).
We have found that human umbilical vein endothelial cells
HUVECs) readily bind and internalise STBEV (Fig. 2). STBEV have
lso been shown to have antiangiogenic and hypertensive effects,sured. Representative histograms for normal (blue) and PE (red) STBEV and the
escence microscopy images of PE placenta sections labelled with FITC conjugated
ucosamine). Arrow heads indicate discrete areas of lectin staining.
inhibiting endothelial cell monolayer growth in vitro and inhibiting
the relaxation of pre-constricted blood vessels ex vivo (Smarason
et al., 1993; Gupta et al., 2005c; Hoegh et al., 2006; Cockell et al.,
1997). Furthermore, culture supernatants from HUVECs treated
with STBEV can activate neutrophils, suggestive of a role for STBEV
in both the endothelial cell dysfunction and excessive inﬂamma-
tory effects in PE (Von Dadelszen et al., 1999). Unlike PE placentae
derived SNA, thought to be more necrotic in nature and which
strongly activated microvascular endothelial cells in vitro (Shen
et al., 2014), no differential effects of PE derived STBEV on endothe-
lial cells have been shown, however the disruptive effects of STBEV
on endothelial cell function demonstrated in vitro and ex vivo
suggest a direct contribution of increased circulating levels of
STBEV to the endothelial dysfunction characteristic to the mater-
nal syndrome of PE. Indirect actions of PE derived STBEV activating
immune cells and platelets, such as those highlighted above, may
also cause divergent reactions in maternal endothelial cells.
4. STBEV functional moieties and novel PE STBEV
biomarkers
STBEV, like many EV studied, carry a complex cargo of proteins,iotrophoblast derived extracellular vesicles in normal pregnancy
16/j.jri.2016.08.008
lipids and miRNAs (recently reviewed by (Tannetta and Sargent,
2013; Tannetta et al., 2014; Mouillet et al., 2015), whilst in PE both
qualitative and quantitative differences in shed STBEV have been
found, such as changes in the size of EV released and the molecular
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argo they carry, that could alter their biological function (Tannetta
nd Sargent, 2013; Tannetta et al., 2013). As with apoptotic cells and
poptotic bodies, ‘eat me’  signals that are recognized by phagocytic
ells may  also play a role in EV-cell interactions and be altered in PE
Biermann et al., 2013). ‘Eat me’  signals include clustered external-
zed PS, PS binding molecules such as annexin A1 and MFG-E8 and
odiﬁed glycosylation, such as reduced sialylation of extracellular
lycans (Biermann et al., 2013; Franz et al., 2007; Meesmann et al.,
010).
Patterns of protein glycosylations affect numerous biological
rocesses including protein folding, cell adhesion and clearance,
olecular trafﬁcking and immune cell responses, to name a few
Lyons et al., 2015; Alavi and Axford, 2006). Membrane proteins
re richly glycosylated. This is also the case for EV membranes and
s used as a mechanism for sorting certain proteins into EV (Batista
t al., 2011; Liang et al., 2014). Disease states can lead to char-
cteristic alterations in cellular glycosylation proﬁles, including,
iabetes, atherosclerosis, neurodegenerative and immune disor-
ers and cancer, where tumour associated glycans have led to
he development of numerous diagnostic and prognostic markers
Almeida and Kolarich, 2016). Again, this has also been found for
V isolated from diseased patients (Gerlach et al., 2013; Staubach
t al., 2012). Using ﬂow cytometry, we investigated sugar moi-
ties found on the surface of normal pregnancy and PE placental
erfusion derived STBEV, by staining with a panel of FITC conju-
ated plant lectins (Fig. 3). Results showed increased staining of PE
erived STBEV with lectins Sambucus nigra, which binds preferen-
ially to sialic acid attached to terminal galactose by -2,6 linkage
SN; p = 0.001) and Ricinus communis agglutinin I, which binds to
alactose or N-acetylgalactosamine residues (RCA 120; p = 0.001)
Fig. 3A). Fluorescence microscopy analysis of PE placenta sections
ith SN and RCA 120 showed discrete areas of STB staining (Fig. 3Bi
nd Bii), very different to the universal staining obtained with
heat germ agglutinin (Fig. 3Biii). As with cell–cell interactions,
urface glycans may  also play a signiﬁcant role in EV-cell interac-
ions. In PE, altered surface glycans may  affect functions such as
ell targeting, clearance and immune activity and may  also have
otential use as markers of placental stress.
. Conclusions
Our understanding of the importance of STBEV in the establish-
ent and maintenance of a healthy pregnancy continues to grow.
hether in vitro studies reveal the biological effects of STBEV in
ivo is not known. Recreating the cytokine, chemokine and hor-
onal milieu of pregnancy for in vitro studies is technically very
hallenging. Also, where primary immune cells have been used,
hese have sometimes been isolated from non-pregnant individ-
als. Better understanding of the biological activity of STBEV in
ormal pregnancy and PE may  uncover new therapeutic targets
uch as neutralizing or removing speciﬁc pathogenic STBEV, using
mmunotherapy or apheresis, or increasing the levels of advanta-
eous STBEV, by either increasing their release or administering the
eneﬁcial bioactive factor. The ultimate goal would be to reduce the
nderlying causes of the maternal syndrome and enable the preg-
ancy to continue for longer, avoiding early pre-term delivery, thus
essening the associated risks to both the baby and mother.
It is clear that much more work is needed to understand the
ntricacies of STBEV subtype biogenesis, mechanisms of action
nd their role over the course of gestation. There is clearer evi-
ence that STBEV contain thousands of proteins, many of whichPlease cite this article in press as: Tannetta, D., et al., Update of syncyt
and preeclampsia. J. Reprod. Immunol. (2016), http://dx.doi.org/10.10
re altered in PE. The examination of STBEV cargo in the maternal
irculation could assist with the detection and management of PE
y giving a real time read out of placental health. Enrichment of
lacental stress indicators, such as altered glycosylation, affecting PRESS
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multiple molecules and their enrichment in STBEV, could also
amplify biomarker signals giving improved sensitivity. However,
clinical use of STBEV requires better isolation methods, precise
markers of EV subtypes and the development of more sensitive
techniques to aid their detection and characterisation.
Ethics statement
Collection of placentas from normal and preeclamptic pregnan-
cies and the isolation of STBEV were approved by the Oxfordshire
Research Ethics Committee C and informed written consent was
obtained from all participants.
Funding
This work was supported by a MRC Programme Grant
(MR/J003360/1).
References
Abumaree, M.H., Stone, P.R., Chamley, L.W., 2006a. The effects of apoptotic:
deported human placental trophoblast on macrophages: possible
consequences for pregnancy. J. Reprod. Immunol. 72, 33–45.
Abumaree, M.H., Stone, P.R., Chamley, L.W., 2006b. An in vitro model of human
placental trophoblast deportation/shedding. Mol. Hum. Reprod. 12, 687–694.
Abumaree, M.H., Chamley, L.W., Badri, M.,  El-Muzaini, M.F., 2012. Trophoblast
debris modulates the expression of immune proteins in macrophages: a key to
maternal tolerance of the fetal allograft? J. Reprod. Immunol. 94, 131–141.
Alavi, A., Axford, J.S., 2006. The pivotal nature of sugars in normal physiology and
disease. Wien. Med. Wochenschr. 156, 19–33.
Almeida, A., Kolarich, D., 2016. The promise of protein glycosylation for
personalised medicine. Biochim. Biophys. Acta. 1860, 1583–1595.
Aly, A.S., Khandelwal, M.,  Zhao, J., Mehmet, A.H., Sammel, M.D., Parry, S., 2004.
Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to
generate superoxide radicals in women with preeclampsia. Am.  J. Obstet.
Gynecol. 190, 252–258.
Amsalem, H., Kwan, M., Hazan, A., Zhang, J., Jones, R.L., Whittle, W.,  Kingdom, J.C.,
Croy, B.A., Lye, S.J., Dunk, C.E., 2014. Identiﬁcation of a novel neutrophil
population: proangiogenic granulocytes in second-trimester human decidua. J.
Immunol. 193, 3070–3079.
An, T.X., Qin, S.H., Xu, Y., Tang, Y.T., Huang, Y.Y., Bo, S.T., Inal, J.M., Zheng, L., 2015.
Exosomes serve as tumour markers for personalized diagnostics owing to their
important role in cancer metastasis. J. Extracell. Vesicles 4.
Andreu, Z., Yanez-Mo, M.,  2014. Tetraspanins in extracellular vesicle formation and
function. Front. Immunol. 5 (442).
Arck, P.C., Hecher, K., Solano, M.E., 2015. B cells in pregnancy: functional
promiscuity or tailored function? Biol. Reprod. 92, 12.
Arkwright, P.D., Rademacher, T.W., Boutignon, F., Dwek, R.A., Redman, C.W., 1994.
Suppression of allogeneic reactivity in vitro by the syncytiotrophoblast
membrane glycocalyx of the human term placenta is carbohydrate dependent.
Glycobiology 4, 39–47.
Atay, S., Gercel-Taylor, C., Taylor, D.D., 2011. Human trophoblast-derived exosomal
ﬁbronectin induces pro-inﬂammatory IL-1beta production by macrophages.
Am.  J. Reprod. Immunol. 66, 259–269.
Bao, Y., Cao, X., 2014. The immune potential and immunopathology of
cytokine-producing B cell subsets: a comprehensive review. J. Autoimmun. 55,
10–23.
Batista, B.S., Eng, W.S., Pilobello, K.T., Hendricks-Munoz, K.D., Mahal, L.K., 2011.
Identiﬁcation of a conserved glycan signature for microvesicles. J. Proteome
Res. 10, 4624–4633.
Biermann, M.,  Maueroder, C., Brauner, J.M., Chaurio, R., Janko, C., Herrmann, M.,
Munoz, L.E., 2013. Surface code-biophysical signals for apoptotic cell clearance.
Phys. Biol., 10.
Boing, A.N., Van Der Pol, E., Grootemaat, A.E., Coumans, F.A., Sturk, A., Nieuwland,
R.,  2014. Single-step isolation of extracellular vesicles by size-exclusion
chromatography. J. Extracell. Vesicles 3.
Burton, G.J., Fowden, A.L., 2015. The placenta: a multifaceted, transient organ.
Philos. Trans. R Soc. Lond. B Biol. Sci. 370, 20140066.
Burton, G.J., Jones, C.J., 2009. Syncytial knots, sprouts, apoptosis, and trophoblast
deportation from the human placenta. Taiwan J. Obstet. Gynecol. 48, 28–37.
Burton, G.J., Yung, H.W., 2011. Endoplasmic reticulum stress in the pathogenesis of
early-onset pre-eclampsia. Pregnancy Hypertens. 1, 72–78.
Chamley, L.W., Chen, Q., Ding, J., Stone, P.R., Abumaree, M.,  2011. Trophoblast
deportation: just a waste disposal system or antigen sharing? J. Reprod.
Immunol. 88, 99–105.iotrophoblast derived extracellular vesicles in normal pregnancy
16/j.jri.2016.08.008
Chen, Q., Stone, P.R., Mccowan, L.M., Chamley, L.W., 2006. Phagocytosis of necrotic
but  not apoptotic trophoblasts induces endothelial cell activation.
Hypertension 47, 116–121.
Chen, Q., Chen, L., Liu, B., Vialli, C., Stone, P., Ching, L.M., Chamley, L., 2010. The role
of  autocrine TGFbeta1 in endothelial cell activation induced by phagocytosis of
 ING ModelJ
8 ductiv
C
C
C
C
D
D
D
F
F
G
G
G
G
G
G
G
G
G
H
H
H
H
H
H
H
JARTICLERI-2436; No. of Pages 9
 D. Tannetta et al. / Journal of Repro
necrotic trophoblasts: a possible role in the pathogenesis of pre-eclampsia. J.
Pathol. 221, 87–95.
hen, Q., Guo, F., Jin, H.Y., Lau, S., Stone, P., Chamley, L., 2012a. Phagocytosis of
apoptotic trophoblastic debris protects endothelial cells against activation.
Placenta 33, 548–553.
hen, Y., Huang, Y., Jiang, R., Teng, Y., 2012b. Syncytiotrophoblast-derived
microparticle shedding in early-onset and late-onset severe pre-eclampsia. Int.
J.  Gynaecol. Obstet. 119, 234–238.
ockell, A.P., Learmont, J.G., Smarason, A.K., Redman, C.W., Sargent, I.L., Poston, L.,
1997. Human placental syncytiotrophoblast microvillous membranes impair
maternal vascular endothelial function. Br. J. Obstet. Gynaecol. 104, 235–240.
olombo, M.,  Raposo, G., Thery, C., 2014. Biogenesis, secretion, and intercellular
interactions of exosomes and other extracellular vesicles. Ann. Rev. Cell Dev.
Biol. 30, 255–289.
ragovic, R.A., Gardiner, C., Brooks, A.S., Tannetta, D.S., Ferguson, D.J., Hole, P., Carr,
B.,  Redman, C.W., Harris, A.L., Dobson, P.J., Harrison, P., Sargent, I.L., 2011.
Sizing and phenotyping of cellular vesicles using nanoparticle tracking
analysis. Nanomedicine 7, 780–788.
ragovic, R.A., Southcombe, J.H., Tannetta, D.S., Redman, C.W., Sargent, I.L., 2013.
Multicolor ﬂow cytometry and nanoparticle tracking analysis of extracellular
vesicles in the plasma of normal pregnant and pre-eclamptic women. Biol.
Reprod. 89, 151.
ragovic, R.A., Collett, G.P., Hole, P., Ferguson, D.J., Redman, C.W., Sargent, I.L.,
Tannetta, D.S., 2015. Isolation of syncytiotrophoblast microvesicles and
exosomes and their characterisation by multicolour ﬂow cytometry and
ﬂuorescence nanoparticle tracking analysis. Methods 87, 64–74.
ranz, S., Herrmann, K., Fuehrnrohr, B., Sheriff, A., Frey, B., Gaipl, U.S., Voll, R.E.,
Kalden, J.R., Jaeck, H.M., Herrmann, M.,  2007. After shrinkage apoptotic cells
expose internal membrane-derived epitopes on their plasma membranes. Cell
Death Differ. 14, 733–742.
riand, V., David, G., Zimmermann, P., 2015. Syntenin and syndecan in the
biogenesis of exosomes. Biol. Cell 107, 331–341.
ardiner, C., Tannetta, D.S., Simms, C.A., Harrison, P., Redman, C.W., Sargent, I.L.,
2011. Syncytiotrophoblast microvesicles released from pre-eclampsia
placentae exhibit increased tissue factor activity. PLoS One 6, e26313.
elber, S.E., Brent, E., Redecha, P., Perino, G., Tomlinson, S., Davisson, R.L., Salmon,
J.E., 2015. Prevention of defective placentation and pregnancy loss by blocking
innate immune pathways in a syngeneic model of placental insufﬁciency. J.
Immunol. 195, 1129–1138.
erlach, J.Q., Kruger, A., Gallogly, S., Hanley, S.A., Hogan, M.C., Ward, C.J., Joshi, L.,
Grifﬁn, M.D., 2013. Surface glycosylation proﬁles of urine extracellular vesicles.
PLoS One 8, e74801.
ermain, S.J., Sacks, G.P., Sooranna, S.R., Sargent, I.L., Redman, C.W., 2007. Systemic
inﬂammatory priming in normal pregnancy and preeclampsia: the role of
circulating syncytiotrophoblast microparticles. J. Immunol. 178, 5949–5956.
oswami, D., Tannetta, D.S., Magee, L.A., Fuchisawa, A., Redman, C.W., Sargent, I.L.,
Von  Dadelszen, P., 2006. Excess syncytiotrophoblast microparticle shedding is
a  feature of early-onset pre-eclampsia: but not normotensive intrauterine
growth restriction. Placenta 27, 56–61.
udbergsson, J.M., Johnsen, K.B., Skov, M.N., Duroux, M.,  2016. Systematic review
of factors inﬂuencing extracellular vesicle yield from cell cultures.
Cytotechnology 68, 579–592.
upta, A.K., Hasler, P., Holzgreve, W.,  Gebhardt, S., Hahn, S., 2005a. Induction of
neutrophil extracellular DNA lattices by placental microparticles and IL-8 and
their presence in preeclampsia. Hum. Immunol. 66, 1146–1154.
upta, A.K., Rusterholz, C., Holzgreve, W.,  Hahn, S., 2005b. Syncytiotrophoblast
micro-particles do not induce apoptosis in peripheral T lymphocytes, but differ
in  their activity depending on the mode of preparation. J. Reprod. Immunol. 68,
15–26.
upta, A.K., Rusterholz, C., Huppertz, B., Malek, A., Schneider, H., Holzgreve, W.,
Hahn, S., 2005c. A comparative study of the effect of three different
syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta
26,  59–66.
anson, P.I., Cashikar, A., 2012. Multivesicular body morphogenesis. Ann. Rev. Cell
Dev. Biol. 28, 337–362.
edlund, M.,  Stenqvist, A.C., Nagaeva, O., Kjellberg, L., Wulff, M.,  Baranov, V.,
Mincheva-Nilsson, L., 2009. Human placenta expresses and secretes NKG2D
ligands via exosomes that down-modulate the cognate receptor expression:
evidence for immunosuppressive function. J. Immunol. 183, 340–351.
enne, W.M.,  Buchkovich, N.J., Emr, S.D., 2011. The ESCRT pathway. Dev. Cell 21,
77–91.
oegh, A.M., Tannetta, D., Sargent, I., Borup, R., Nielsen, F.C., Redman, C., Sorensen,
S., Hviid, T.V., 2006. Effect of syncytiotrophoblast microvillous membrane
treatment on gene expression in human umbilical vein endothelial cells. BJOG
113, 1270–1279.
older, B.S., Tower, C.L., Jones, C.J., Aplin, J.D., Abrahams, V.M., 2012. Heightened
pro-inﬂammatory effect of preeclamptic placental microvesicles on peripheral
blood immune cells in humans. Biol. Reprod. 86, 103.
olland, O.J., Linscheid, C., Hodes, H.C., Nauser, T.L., Gilliam, M.,  Stone, P., Chamley,
L.W., Petroff, M.G., 2012. Minor histocompatibility antigens are expressed in
syncytiotrophoblast and trophoblast debris: implications for maternalPlease cite this article in press as: Tannetta, D., et al., Update of syncyt
and preeclampsia. J. Reprod. Immunol. (2016), http://dx.doi.org/10.10
alloreactivity to the fetus. Am.  J. Pathol. 180, 256–266.
uppertz, B., Kadyrov, M.,  Kingdom, J.C., 2006. Apoptosis and its role in the
trophoblast. Am.  J. Obstet. Gynecol. 195, 29–39.
ohansen, M.,  Redman, C.W., Wilkins, T., Sargent, I.L., 1999. Trophoblast deportation
in  human pregnancy–its relevance for pre-eclampsia. Placenta 20, 531–539. PRESS
e Immunology xxx (2016) xxx–xxx
Kalra, H., Drummen, G.P., Mathivanan, S., 2016. Focus on extracellular vesicles:
introducing the next small big thing. Int. J. Mol. Sci. 17.
Knight, M.,  Redman, C.W., Linton, E.A., Sargent, I.L., 1998. Shedding of
syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic
pregnancies. Br. J. Obstet. Gynaecol. 105, 632–640.
Liang, Y.X., Eng, W.S., Colquhoun, D.R., Dinglasan, R.R., Graham, D.R., Mahal, L.K.,
2014. Complex N-linked glycans serve as a determinant for
exosome/microvesicle cargo recruitment. J. Biol. Chem. 289.
Linscheid, C., Heitmann, E., Singh, P., Wickstrom, E., Qiu, L., Hodes, H., Nauser, T.,
Petroff, M.G., 2015. Trophoblast expression of the minor histocompatibility
antigen HA-1 is regulated by oxygen and is increased in placentas from
preeclamptic women. Placenta 36, 832–838.
Lok, C.A., Van Der Post, J.A., Sargent, I.L., Hau, C.M., Sturk, A., Boer, K., Nieuwland, R.,
2008. Changes in microparticle numbers and cellular origin during pregnancy
and preeclampsia. Hypertens. Pregnancy 27, 344–360.
Lyons, J.J., Milner, J.D., Rosenzweig, S.D., 2015. Glycans instructing immunity: the
emerging role of altered glycosylation in clinical immunology. Front. Pediatr. 3
(54).
Macey, M.G., Bevan, S., Alam, S., Verghese, L., Agrawal, S., Beski, S., Thuraisingham,
R.,  Maccallum, P.K., 2010. Platelet activation and endogenous thrombin
potential in pre-eclampsia. Thromb. Res. 125, e76–81.
Marques, F., Campos, F.M., Filho, O.A., Carvalho, A.T., Dusse, L.M., Gomes, K.B., 2012.
Circulating microparticles in severe preeclampsia. Clin. Chim. Acta. 414,
253–258.
Mazurov, D., Barbashova, L., Filatov, A., 2013. Tetraspanin protein CD9 interacts
with metalloprotease CD10 and enhances its release via exosomes. FEBS J. 280,
1200–1213.
Meesmann, H.M., Fehr, E.M., Kierschke, S., Herrmann, M.,  Bilyy, R., Heyder, P.,
Blank, N., Krienke, S., Lorenz, H.M., Schiller, M.,  2010. Decrease of sialic acid
residues as an eat-me signal on the surface of apoptotic lymphocytes. J. Cell
Sci.  123, 3347–3356.
Messerli, M.,  May, K., Hansson, S.R., Schneider, H., Holzgreve, W.,  Hahn, S.,
Rusterholz, C., 2010. Feto-maternal interactions in pregnancies: placental
microparticles activate peripheral blood monocytes. Placenta 31, 106–112.
Mincheva-Nilsson, L., Nagaeva, O., Chen, T., Stendahl, U., Antsiferova, J., Mogren, I.,
Hernestal, J., Baranov, V., 2006. Placenta-derived soluble MHC  class I
chain-related molecules down-regulate NKG2D receptor on peripheral blood
mononuclear cells during human pregnancy: a possible novel immune escape
mechanism for fetal survival. J. Immunol. 176, 3585–3592.
Momen-Heravi, F., Balaj, L., Alian, S., Mantel, P.Y., Halleck, A.E., Trachtenberg, A.J.,
Soria, C.E., Oquin, S., Bonebreak, C.M., Saracoglu, E., Skog, J., Kuo, W.P., 2013.
Current methods for the isolation of extracellular vesicles. Biol. Chem. 394,
1253–1262.
Mouillet, J.F., Ouyang, Y.S., Coyne, C.B., Sadovsky, Y., 2015. MicroRNAs in placental
health and disease. Am. J. Obstet. Gynecol. 213, S163–S172.
Moulin, V., Andris, F., Thielemans, K., Maliszewski, C., Urbain, J., Moser, M.,  2000. B
lymphocytes regulate dendritic cell (DC) function in vivo: increased
interleukin 12 production by DCs from B cell-deﬁcient mice results in T helper
cell  type 1 deviation. J. Exp. Med. 192, 475–482.
Nancy, P., Erlebacher, A., 2014. T cell behavior at the maternal-fetal interface. Int. J.
Dev. Biol. 58, 189–198.
Orozco, A.F., Jorgez, C.J., Ramos-Perez, W.D., Popek, E.J., Yu, X., Kozinetz, C.A.,
Bischoff, F.Z., Lewis, D.E., 2009. Placental release of distinct DNA-associated
micro-particles into maternal circulation: reﬂective of gestation time and
preeclampsia. Placenta 30, 891–897.
Raposo, G., Stoorvogel, W.,  2013. Extracellular vesicles: exosomes, microvesicles,
and friends. J. Cell Biol. 200, 373–383.
Reddy, A., Zhong, X.Y., Rusterholz, C., Hahn, S., Holzgreve, W.,  Redman, C.W.,
Sargent, I.L., 2008. The effect of labour and placental separation on the
shedding of syncytiotrophoblast microparticles: cell-free DNA and mRNA in
normal pregnancy and pre-eclampsia. Placenta 29, 942–949.
Redman, C.W., Sargent, I.L., 2005. Latest advances in understanding preeclampsia.
Science 308, 1592–1594.
Redman, C.W., Tannetta, D.S., Dragovic, R.A., Gardiner, C., Southcombe, J.H., Collett,
G.P., Sargent, I.L., 2012. Review: does size matter? Placental debris and the
pathophysiology of pre-eclampsia. Placenta 33 (Suppl), S48–S54.
Reverdiau, P., Jarousseau, A.C., Thibault, G., Khalfoun, B., Watier, H., Lebranchu, Y.,
Bardos, P., Gruel, Y., 1995. Tissue factor activity of syncytiotrophoblast plasma
membranes and tumoral trophoblast cells in culture. Thromb. Haemost. 73,
49–54.
Sabapatha, A., Gercel-Taylor, C., Taylor, D.D., 2006. Speciﬁc isolation of
placenta-derived exosomes from the circulation of pregnant women  and their
immunoregulatory consequences. Am. J. Reprod. Immunol. 56, 345–355.
Sacks, G.P., Studena, K., Sargent, K., Redman, C.W., 1998. Normal pregnancy and
preeclampsia both produce inﬂammatory changes in peripheral blood
leukocytes akin to those of sepsis. Am.  J. Obstet. Gynecol. 179, 80–86.
Salomon, C., Torres, M.J., Kobayashi, M., Scholz-Romero, K., Sobrevia, L.,
Dobierzewska, A., Illanes, S.E., Mitchell, M.D., Rice, G.E., 2014. A gestational
proﬁle of placental exosomes in maternal plasma and their effects on
endothelial cell migration. PLoS One 9, e98667.
Sargent, I., 2013. Microvesicles and pre-eclampsia. Pregnancy Hypertens. 3, 58.iotrophoblast derived extracellular vesicles in normal pregnancy
16/j.jri.2016.08.008
Shen, F., Wei, J., Snowise, S., Desousa, J., Stone, P., Viall, C., Chen, Q., Chamley, L.,
2014. Trophoblast debris extruded from preeclamptic placentae activates
endothelial cells: a mechanism by which the placenta communicates with the
maternal endothelium. Placenta 35, 839–847.
 ING ModelJ
ductiv
S
S
S
S
S
T
T
T
T
T
vesicle isolation and characterization: toward clinical application. J. Clin.ARTICLERI-2436; No. of Pages 9
D. Tannetta et al. / Journal of Repro
marason, A.K., Sargent, I.L., Starkey, P.M., Redman, C.W., 1993. The effect of
placental syncytiotrophoblast microvillous membranes from normal and
pre-eclamptic women on the growth of endothelial cells in vitro. Br. J. Obstet.
Gynaecol. 100, 943–949.
outhcombe, J., Tannetta, D., Redman, C., Sargent, I., 2011. The immunomodulatory
role of syncytiotrophoblast microvesicles. PLoS One 6, e20245.
taubach, S., Schadewaldt, P., Wendel, U., Nohroudi, K., Hanisch, F.G., 2012.
Differential glycomics of epithelial membrane glycoproteins from urinary
exovesicles reveals shifts toward complex-type N-glycosylation in classical
galactosemia. J. Proteome Res. 11, 906–916.
tenqvist, A.C., Nagaeva, O., Baranov, V., Mincheva-Nilsson, L., 2013. Exosomes
secreted by human placenta carry functional Fas ligand and TRAIL molecules
and  convey apoptosis in activated immune cells, suggesting
exosome-mediated immune privilege of the fetus. J. Immunol. 191, 5515–5523.
tuffers, S., Sem Wegner, C., Stenmark, H., Brech, A., 2009. Multivesicular
endosome biogenesis in the absence of ESCRTs. Trafﬁc 10, 925–937.
annetta, D., Sargent, I., 2013. Placental disease and the maternal syndrome of
preeclampsia: missing links? Curr. Hypertens. Rep. 15, 590–599.
annetta, D.S., Dragovic, R.A., Gardiner, C., Redman, C.W., Sargent, I.L., 2013.
Characterisation of syncytiotrophoblast vesicles in normal pregnancy and
pre-eclampsia: expression of Flt-1 and endoglin. PLoS One 8, e56754.
annetta, D., Dragovic, R., Alyahyaei, Z., Southcombe, J., 2014. Extracellular vesicles
and reproduction-promotion of successful pregnancy. Cell Mol. Immunol. 11,
548–563.
annetta, D.S., Hunt, K., Jones, C.I., Davidson, N., Coxon, C.H., Ferguson, D., Redman,
C.W., Gibbins, J.M., Sargent, I.L., Tucker, K.L., 2015. SyncytiotrophoblastPlease cite this article in press as: Tannetta, D., et al., Update of syncyt
and preeclampsia. J. Reprod. Immunol. (2016), http://dx.doi.org/10.10
extracellular vesicles from pre-eclampsia placentas differentially affect
platelet function. PLoS One 10, e0142538.
ay, C.S., Tagliani, E., Collins, M.K., Erlebacher, A., 2013. Cis-acting pathways
selectively enforce the non-immunogenicity of shed placental antigen for
maternal CD8T cells. PLoS One 8, e84064. PRESS
e Immunology xxx (2016) xxx–xxx 9
Taylor, D.D., Akyol, S., Gercel-Taylor, C., 2006. Pregnancy-associated exosomes and
their modulation of T cell signaling. J. Immunol. 176, 1534–1542.
Thibault, G., Degenne, D., Girard, A.C., Guillaumin, J.M., Lacord, M.,  Bardos, P., 1991.
The inhibitory effect of human syncytiotrophoblast plasma membrane vesicles
on in vitro lymphocyte proliferation is associated with reduced interleukin 2
receptor expression. Cell. Immunol. 138, 165–174.
Van Deun, J., Mestdagh, P., Sormunen, R., Cocquyt, V., Vermaelen, K.,
Vandesompele, J., Bracke, M.,  Wever, D.E., Hendrix, O., 2014. The impact of
disparate isolation methods for extracellular vesicles on downstream RNA
proﬁling. J. Extracell. Vesicles 3.
Villarroya-Beltri, C., Baixauli, F., Gutierrez-Vazquez, C., Sanchez-Madrid, F.,
Mittelbrunn, M.,  2014. Sorting it out: regulation of exosome loading. Semin.
Cancer Biol. 28, 3–13.
Von Dadelszen, P., Hurst, G., Redman, C.W., 1999. Supernatants from co-cultured
endothelial cells and syncytiotrophoblast microvillous membranes activate
peripheral blood leukocytes in vitro. Hum. Reprod. 14, 919–924.
Wei, J., Lau, S.Y., Blenkiron, C., Chen, Q., James, J.L., Kleffmann, T., Wise, M.,  Stone,
P.R., Chamley, L.W., 2016. Trophoblastic debris modiﬁes endothelial cell
transcriptome in vitro: a mechanism by which fetal cells might control
maternal responses to pregnancy. Sci. Rep. 6, 30632.
Witwer, K.W., Buzas, E.I., Bemis, L.T., Bora, A., Lasser, C., Lotvall, J., NOLTE-’T Hoen,
E.N.,  Piper, M.G., Sivaraman, S., Skog, J., Thery, C., Wauben, M.H., Hochberg, F.,
2013. Standardization of sample collection, isolation and analysis methods in
extracellular vesicle research. J. Extracell. Vesicles 2.
Xu, R., Greening, D.W., Zhu, H.J., Takahashi, N., Simpson, R.J., 2016. Extracellulariotrophoblast derived extracellular vesicles in normal pregnancy
16/j.jri.2016.08.008
Invest. 126, 1152–1162.
Yuana, Y., Levels, J., Grootemaat, A., Sturk, A., Nieuwland, R., 2014. Co-isolation of
extracellular vesicles and high-density lipoproteins using density gradient
ultracentrifugation. J. Extracell. Vesicles 3.
